Project
PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Navigation
Downloads
Results for Taf1
Z-value: 3.85
Motif logo
Transcription factors associated with Taf1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
Taf1
|
ENSMUSG00000031314.19 | Taf1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Taf1 | mm39_v1_chrX_+_100576340_100576383 | 0.51 | 5.8e-06 | Click! |
Activity profile of Taf1 motif
Sorted Z-values of Taf1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of Taf1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 16.0 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 5.0 | 15.0 | GO:0035037 | sperm entry(GO:0035037) |
| 4.8 | 23.9 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
| 4.0 | 24.2 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 3.9 | 19.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 3.7 | 14.8 | GO:0017126 | nucleologenesis(GO:0017126) |
| 3.2 | 12.9 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 3.0 | 30.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 2.9 | 8.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 2.7 | 8.1 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 2.7 | 26.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 2.7 | 8.0 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 2.7 | 15.9 | GO:1901580 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 2.6 | 44.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 2.5 | 19.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 2.3 | 9.4 | GO:0019046 | release from viral latency(GO:0019046) |
| 2.3 | 11.6 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 2.3 | 11.4 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
| 2.3 | 9.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 2.2 | 24.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 2.2 | 10.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 2.1 | 10.7 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.1 | 20.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 2.1 | 6.2 | GO:1990428 | miRNA transport(GO:1990428) |
| 2.0 | 2.0 | GO:2000011 | adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
| 2.0 | 7.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 2.0 | 2.0 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
| 1.9 | 7.7 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) RNA repair(GO:0042245) |
| 1.9 | 9.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 1.9 | 9.6 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 1.9 | 76.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 1.9 | 20.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 1.8 | 18.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.8 | 9.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.8 | 5.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.7 | 6.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 1.7 | 32.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 1.7 | 6.8 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 1.7 | 1.7 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
| 1.6 | 6.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.6 | 4.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.6 | 6.3 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.6 | 11.0 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 1.6 | 6.3 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 1.6 | 6.2 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 1.5 | 3.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 1.5 | 7.7 | GO:1901297 | positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 1.5 | 9.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 1.5 | 7.5 | GO:0090669 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) telomerase RNA stabilization(GO:0090669) |
| 1.5 | 4.5 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 1.5 | 1.5 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
| 1.5 | 10.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 1.4 | 4.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 1.4 | 11.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 1.4 | 14.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 1.4 | 4.2 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 1.4 | 28.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 1.4 | 4.1 | GO:0014737 | positive regulation of muscle atrophy(GO:0014737) |
| 1.4 | 4.1 | GO:0034117 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
| 1.4 | 6.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 1.3 | 4.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 1.3 | 4.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 1.3 | 9.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 1.3 | 6.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 1.2 | 4.9 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 1.2 | 3.7 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 1.2 | 8.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 1.2 | 4.7 | GO:0050822 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 1.2 | 10.6 | GO:0090169 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
| 1.2 | 3.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.2 | 4.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.2 | 2.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 1.1 | 3.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.1 | 8.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 1.1 | 4.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 1.1 | 3.4 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 1.1 | 13.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 1.1 | 3.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 1.1 | 4.3 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 1.1 | 3.2 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 1.1 | 7.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.1 | 7.4 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.1 | 4.2 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 1.0 | 7.3 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 1.0 | 11.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 1.0 | 4.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.0 | 4.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 1.0 | 3.1 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 1.0 | 4.1 | GO:0006272 | leading strand elongation(GO:0006272) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 1.0 | 6.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 1.0 | 4.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 1.0 | 2.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 1.0 | 4.0 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 1.0 | 2.9 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 1.0 | 5.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 1.0 | 8.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.9 | 2.8 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.9 | 2.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.9 | 3.7 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.9 | 3.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.9 | 8.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.9 | 5.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.9 | 3.7 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.9 | 3.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.9 | 14.5 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.9 | 4.5 | GO:0000432 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.9 | 2.7 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.9 | 4.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.9 | 1.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.9 | 7.0 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
| 0.9 | 4.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.9 | 2.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
| 0.9 | 1.7 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.8 | 2.5 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.8 | 0.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 0.8 | 1.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.8 | 5.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.8 | 8.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.8 | 16.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.8 | 6.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.8 | 5.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.8 | 8.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.8 | 13.8 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.8 | 2.4 | GO:1903699 | tarsal gland development(GO:1903699) |
| 0.8 | 3.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
| 0.8 | 3.2 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.8 | 4.7 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.8 | 2.4 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.8 | 3.9 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.8 | 3.9 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.8 | 5.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.8 | 4.7 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.8 | 3.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.8 | 2.3 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.8 | 2.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.8 | 3.1 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.8 | 10.7 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.8 | 10.5 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.7 | 2.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.7 | 2.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
| 0.7 | 8.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.7 | 5.8 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) tachykinin receptor signaling pathway(GO:0007217) follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.7 | 2.9 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.7 | 12.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.7 | 2.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.7 | 2.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.7 | 5.0 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.7 | 7.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.7 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.7 | 7.8 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.7 | 1.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.7 | 2.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.7 | 1.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.7 | 1.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.7 | 2.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.7 | 8.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.7 | 18.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.7 | 3.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 | 3.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.7 | 2.0 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
| 0.7 | 5.2 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.6 | 4.5 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.6 | 3.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.6 | 10.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.6 | 1.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.6 | 2.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.6 | 6.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.6 | 6.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.6 | 1.9 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.6 | 3.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.6 | 6.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.6 | 15.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.6 | 2.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.6 | 2.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
| 0.6 | 1.2 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.6 | 1.2 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.6 | 1.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.6 | 10.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.6 | 4.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.6 | 4.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.6 | 1.7 | GO:1902226 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
| 0.6 | 2.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.6 | 2.2 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.6 | 2.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.5 | 16.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.5 | 6.6 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.5 | 3.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.5 | 2.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.5 | 6.4 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.5 | 12.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.5 | 3.6 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.5 | 7.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.5 | 5.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.5 | 5.6 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.5 | 12.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.5 | 4.4 | GO:0034088 | maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.5 | 8.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.5 | 5.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.5 | 3.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.5 | 1.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.5 | 10.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.5 | 2.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.5 | 1.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.5 | 5.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.5 | 12.3 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.5 | 1.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.5 | 1.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 | 1.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.5 | 11.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.5 | 5.5 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.5 | 13.7 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.5 | 1.4 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
| 0.5 | 12.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.5 | 5.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.5 | 2.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
| 0.4 | 29.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.4 | 4.9 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.4 | 4.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.4 | 1.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.4 | 18.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.4 | 3.1 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.4 | 5.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.4 | 5.6 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.4 | 10.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.4 | 13.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.4 | 1.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 | 8.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.4 | 1.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.4 | 10.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.4 | 15.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.4 | 6.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 | 2.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.4 | 2.0 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.4 | 4.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.4 | 5.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.4 | 1.2 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.4 | 25.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.4 | 5.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.4 | 7.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.4 | 11.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.4 | 5.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.4 | 3.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.4 | 4.3 | GO:0015074 | DNA integration(GO:0015074) |
| 0.4 | 11.6 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.4 | 4.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.4 | 1.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.4 | 0.8 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.4 | 1.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.4 | 6.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.4 | 2.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.4 | 8.5 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.4 | 2.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.4 | 16.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.4 | 1.1 | GO:1990117 | release of matrix enzymes from mitochondria(GO:0032976) B cell receptor apoptotic signaling pathway(GO:1990117) |
| 0.4 | 2.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.4 | 2.9 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.4 | 2.5 | GO:0097240 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.4 | 1.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 | 2.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.4 | 2.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.4 | 1.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.3 | 2.4 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.3 | 1.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 0.3 | 4.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.3 | 3.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.3 | 4.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.3 | 9.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.3 | 2.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.3 | 2.0 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.3 | 1.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.3 | 2.7 | GO:0016246 | RNA interference(GO:0016246) |
| 0.3 | 1.3 | GO:0033762 | response to glucagon(GO:0033762) |
| 0.3 | 9.0 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.3 | 2.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.3 | 1.6 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.3 | 2.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.3 | 2.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 14.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.3 | 1.6 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 | 7.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.3 | 1.3 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.3 | 1.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.3 | 2.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.3 | 8.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.3 | 4.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.3 | 2.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 | 2.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 | 2.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 3.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.3 | 7.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.3 | 2.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.3 | 12.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.3 | 10.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.3 | 1.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.3 | 2.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.3 | 94.5 | GO:0006397 | mRNA processing(GO:0006397) |
| 0.3 | 1.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.3 | 4.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.3 | 0.9 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 0.3 | 1.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.3 | 1.7 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
| 0.3 | 0.9 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.3 | 3.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.3 | 5.4 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
| 0.3 | 1.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.3 | 1.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 | 20.8 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.3 | 0.8 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.3 | 5.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.3 | 3.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.3 | 2.8 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.3 | 3.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.3 | 2.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 | 12.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.3 | 0.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.3 | 7.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.3 | 8.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.3 | 1.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.3 | 7.3 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.3 | 0.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.3 | 4.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.3 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.3 | 0.8 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.3 | 2.8 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 7.6 | GO:0038066 | p38MAPK cascade(GO:0038066) |
| 0.3 | 1.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.3 | 1.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.2 | 0.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.2 | 4.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.2 | 2.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.2 | 3.2 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.2 | 1.5 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 | 2.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.2 | 3.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 0.2 | 4.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.2 | 12.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.2 | 2.8 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
| 0.2 | 3.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.2 | 1.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 7.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.2 | 5.1 | GO:0060746 | parental behavior(GO:0060746) |
| 0.2 | 5.3 | GO:0007099 | centriole replication(GO:0007099) |
| 0.2 | 2.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 | 3.4 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 | 0.5 | GO:0098749 | cerebellar neuron development(GO:0098749) |
| 0.2 | 15.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.2 | 11.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.2 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 4.6 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.2 | 2.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.2 | 2.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.2 | 2.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.2 | 3.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.2 | 1.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 | 1.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 | 4.4 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 4.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.2 | 0.4 | GO:0009838 | abscission(GO:0009838) |
| 0.2 | 5.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.2 | 3.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 0.2 | 2.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
| 0.2 | 1.6 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.2 | 7.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.2 | 6.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.2 | 1.0 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.2 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 5.8 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 | 0.4 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 | 3.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.2 | 1.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 2.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.2 | 1.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 | 2.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.9 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 | 2.6 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.2 | 2.8 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.2 | 6.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.2 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 2.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 1.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.2 | 13.3 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
| 0.2 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
| 0.2 | 8.8 | GO:0017145 | stem cell division(GO:0017145) |
| 0.2 | 1.0 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.2 | 1.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.2 | 0.6 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 0.2 | 1.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 1.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 | 4.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 | 0.3 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.2 | 8.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.2 | 3.0 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.2 | 4.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.1 | 0.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.1 | 1.2 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.1 | 5.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.1 | 0.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 3.8 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 0.4 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.1 | 3.4 | GO:0003170 | heart valve development(GO:0003170) |
| 0.1 | 2.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.9 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.1 | 1.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.1 | 2.0 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 2.8 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 3.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.1 | 0.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 | 6.0 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 1.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 | 2.9 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 9.3 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.1 | 1.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 2.9 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.1 | 0.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 1.6 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
| 0.1 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 1.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 1.2 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 0.7 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 2.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 | 1.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 1.9 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 | 0.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 | 11.1 | GO:0001892 | embryonic placenta development(GO:0001892) |
| 0.1 | 1.2 | GO:0006275 | regulation of DNA replication(GO:0006275) |
| 0.1 | 2.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 2.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 1.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 | 3.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
| 0.1 | 0.5 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
| 0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 1.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 7.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 1.4 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 1.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 4.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 2.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.3 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.1 | 5.7 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.1 | 1.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 | 1.4 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.1 | 1.4 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.1 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.1 | 0.8 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 1.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 1.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 | 2.5 | GO:0006414 | translational elongation(GO:0006414) |
| 0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.1 | 0.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.1 | 3.3 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.1 | 1.0 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 | 0.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 3.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.1 | 1.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 2.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 7.4 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.1 | 0.3 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.3 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 0.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 1.3 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.1 | 3.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.1 | 4.3 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.1 | 2.4 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
| 0.1 | 2.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 4.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 1.5 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.1 | 2.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
| 0.1 | 2.8 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.1 | 1.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.1 | 0.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 0.8 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.1 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 | 4.0 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 9.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 0.5 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.1 | 0.3 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 1.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.0 | 4.4 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
| 0.0 | 1.7 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
| 0.0 | 1.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
| 0.0 | 2.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 6.3 | GO:0006396 | RNA processing(GO:0006396) |
| 0.0 | 1.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 2.8 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
| 0.0 | 5.2 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 0.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 | 1.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 2.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 1.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 1.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 | 1.9 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.0 | 4.8 | GO:0009615 | response to virus(GO:0009615) |
| 0.0 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.0 | 1.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 | 0.6 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.6 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.0 | 1.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.0 | 0.5 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
| 0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 | 0.5 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 | 1.1 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 | 1.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 3.1 | GO:0032868 | response to insulin(GO:0032868) |
| 0.0 | 2.4 | GO:0001841 | neural tube formation(GO:0001841) |
| 0.0 | 0.9 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.5 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 | 0.8 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.0 | 0.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 | 1.5 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
| 0.0 | 0.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.7 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
| 0.0 | 0.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 | 0.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.0 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.5 | GO:0051297 | centrosome cycle(GO:0007098) centrosome organization(GO:0051297) |
| 0.0 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.0 | 1.1 | GO:0030509 | BMP signaling pathway(GO:0030509) |
| 0.0 | 1.2 | GO:0030217 | T cell differentiation(GO:0030217) |
| 0.0 | 1.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.4 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 4.1 | GO:0045087 | innate immune response(GO:0045087) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 6.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 2.9 | 34.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 2.9 | 28.5 | GO:0042382 | paraspeckles(GO:0042382) |
| 2.7 | 15.9 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
| 2.5 | 30.1 | GO:0000796 | condensin complex(GO:0000796) |
| 2.4 | 14.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 2.4 | 9.5 | GO:0032021 | NELF complex(GO:0032021) |
| 2.3 | 9.2 | GO:0001740 | Barr body(GO:0001740) |
| 2.0 | 8.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 2.0 | 10.0 | GO:0017177 | glucosidase II complex(GO:0017177) |
| 2.0 | 13.7 | GO:0098536 | deuterosome(GO:0098536) |
| 1.9 | 9.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 1.9 | 11.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 1.9 | 7.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 1.8 | 12.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 1.7 | 15.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 1.7 | 55.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 1.7 | 11.8 | GO:0070820 | tertiary granule(GO:0070820) |
| 1.6 | 6.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 1.6 | 11.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 1.5 | 10.5 | GO:0036396 | MIS complex(GO:0036396) |
| 1.5 | 11.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.4 | 9.8 | GO:0005638 | lamin filament(GO:0005638) |
| 1.4 | 43.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 1.4 | 4.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 1.3 | 28.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 1.3 | 26.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 1.3 | 6.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 1.3 | 3.8 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 1.2 | 3.7 | GO:1990423 | RZZ complex(GO:1990423) |
| 1.2 | 14.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 1.2 | 7.3 | GO:0097452 | GAIT complex(GO:0097452) |
| 1.2 | 4.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 1.2 | 4.8 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 1.2 | 4.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 1.2 | 8.2 | GO:0072487 | MSL complex(GO:0072487) |
| 1.2 | 5.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 1.2 | 3.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 1.1 | 19.9 | GO:0000346 | transcription export complex(GO:0000346) |
| 1.1 | 12.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 1.1 | 8.4 | GO:0097422 | extrinsic component of endosome membrane(GO:0031313) tubular endosome(GO:0097422) |
| 1.0 | 6.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 1.0 | 9.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 1.0 | 2.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 1.0 | 5.1 | GO:0044307 | dendritic branch(GO:0044307) |
| 1.0 | 3.0 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 1.0 | 6.8 | GO:0089701 | U2AF(GO:0089701) |
| 0.9 | 8.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.9 | 3.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.9 | 26.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.9 | 30.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.9 | 13.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.8 | 14.0 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.8 | 14.8 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.8 | 4.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.8 | 4.7 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.7 | 24.6 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.7 | 3.7 | GO:0016589 | NURF complex(GO:0016589) |
| 0.7 | 3.0 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.7 | 4.4 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.7 | 2.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.7 | 2.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.7 | 8.7 | GO:0031011 | Ino80 complex(GO:0031011) |
| 0.7 | 2.8 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.7 | 6.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.7 | 36.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.7 | 25.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.7 | 7.5 | GO:0045120 | pronucleus(GO:0045120) |
| 0.7 | 6.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.7 | 2.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.7 | 2.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.7 | 17.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.6 | 1.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.6 | 5.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.6 | 7.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.6 | 5.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.6 | 4.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.6 | 6.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.6 | 16.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.6 | 49.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.6 | 4.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.6 | 3.0 | GO:0001652 | granular component(GO:0001652) |
| 0.6 | 4.7 | GO:0042825 | TAP complex(GO:0042825) |
| 0.6 | 2.3 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.6 | 2.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.6 | 2.3 | GO:0000922 | spindle pole(GO:0000922) |
| 0.6 | 62.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.6 | 1.7 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.5 | 6.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.5 | 10.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.5 | 3.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.5 | 9.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.5 | 19.1 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.5 | 5.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.5 | 46.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.5 | 5.0 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.5 | 27.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.5 | 0.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
| 0.5 | 7.4 | GO:0042555 | MCM complex(GO:0042555) |
| 0.5 | 2.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.5 | 1.9 | GO:0071942 | XPC complex(GO:0071942) |
| 0.5 | 1.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.5 | 2.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.5 | 2.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.5 | 1.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.5 | 2.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.5 | 10.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.4 | 19.6 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.4 | 2.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.4 | 5.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.4 | 4.4 | GO:0002177 | manchette(GO:0002177) |
| 0.4 | 7.0 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.4 | 4.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.4 | 3.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.4 | 6.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.4 | 5.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.4 | 1.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.4 | 4.5 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.4 | 39.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.4 | 6.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.4 | 1.1 | GO:0097144 | BAX complex(GO:0097144) |
| 0.4 | 2.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.4 | 2.8 | GO:0033503 | HULC complex(GO:0033503) |
| 0.3 | 2.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.3 | 3.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 3.7 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 17.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.3 | 12.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
| 0.3 | 62.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.3 | 14.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.3 | 20.7 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.3 | 4.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.3 | 10.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.3 | 4.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.3 | 1.6 | GO:0035363 | histone locus body(GO:0035363) |
| 0.3 | 2.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.3 | 7.0 | GO:0051286 | cell tip(GO:0051286) |
| 0.3 | 1.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.3 | 3.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 1.8 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.3 | 2.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.3 | 2.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.3 | 0.6 | GO:0034456 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
| 0.3 | 5.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.3 | 4.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.3 | 3.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.3 | 1.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.3 | 1.1 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 2.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 1.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 8.9 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.2 | 9.1 | GO:0000791 | euchromatin(GO:0000791) |
| 0.2 | 5.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 6.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.2 | 3.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 7.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.2 | 1.7 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.2 | 2.1 | GO:0070187 | telosome(GO:0070187) |
| 0.2 | 11.7 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.2 | 4.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 18.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.2 | 144.9 | GO:0016604 | nuclear body(GO:0016604) |
| 0.2 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.2 | 1.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.2 | 18.1 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 3.4 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 2.3 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 3.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 10.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
| 0.2 | 8.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.2 | 2.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.2 | 1.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 0.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.2 | 2.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.2 | 4.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 6.1 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 6.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.1 | 3.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.1 | 1.0 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.1 | 2.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 2.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 2.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 2.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.1 | 5.4 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 4.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 27.2 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 7.8 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.1 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 35.8 | GO:0000785 | chromatin(GO:0000785) |
| 0.1 | 14.6 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 0.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.1 | 6.1 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 1.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 3.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 8.4 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 2.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 0.9 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 4.1 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 27.4 | GO:0005694 | chromosome(GO:0005694) |
| 0.1 | 3.2 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 132.9 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.1 | 1.4 | GO:0042581 | specific granule(GO:0042581) |
| 0.1 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.1 | 3.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 4.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 1.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 4.5 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 4.7 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 11.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.1 | 1.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 3.3 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 182.6 | GO:0005634 | nucleus(GO:0005634) |
| 0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 7.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
| 0.0 | 1.4 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 1.3 | GO:0005604 | basement membrane(GO:0005604) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 7.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 2.3 | 15.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 2.3 | 29.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 2.2 | 8.9 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 2.1 | 19.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 2.1 | 8.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 2.0 | 8.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 2.0 | 6.0 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 1.7 | 5.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 1.7 | 17.0 | GO:0050733 | RS domain binding(GO:0050733) |
| 1.7 | 22.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 1.7 | 5.0 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 1.6 | 6.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 1.6 | 4.8 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 1.6 | 4.7 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 1.6 | 6.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.5 | 7.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.5 | 4.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 1.3 | 8.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 1.3 | 4.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 1.3 | 5.1 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 1.2 | 11.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 1.2 | 4.9 | GO:0036033 | mediator complex binding(GO:0036033) |
| 1.2 | 8.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 1.2 | 3.7 | GO:0016509 | long-chain-enoyl-CoA hydratase activity(GO:0016508) long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 1.2 | 6.0 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 1.2 | 11.7 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 1.2 | 6.9 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 1.1 | 6.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 1.1 | 10.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 1.1 | 4.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 1.1 | 8.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 1.1 | 11.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 1.1 | 2.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 1.0 | 6.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 1.0 | 10.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 1.0 | 6.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 1.0 | 5.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 1.0 | 30.5 | GO:0008143 | poly(A) binding(GO:0008143) |
| 1.0 | 4.9 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
| 1.0 | 2.9 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 1.0 | 7.7 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.9 | 2.8 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.9 | 13.6 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.9 | 18.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.9 | 2.7 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.9 | 5.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.9 | 3.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.9 | 6.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.8 | 2.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.8 | 2.4 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.8 | 7.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.8 | 3.2 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.8 | 10.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.8 | 30.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.8 | 11.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.8 | 5.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.8 | 5.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.7 | 4.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.7 | 8.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.7 | 4.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.7 | 3.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.7 | 2.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.7 | 5.1 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.7 | 6.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.7 | 11.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.7 | 2.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.7 | 29.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.7 | 2.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.7 | 6.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.7 | 4.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
| 0.7 | 2.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.7 | 5.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.7 | 7.3 | GO:0043426 | MRF binding(GO:0043426) |
| 0.6 | 3.9 | GO:0070728 | leucine binding(GO:0070728) |
| 0.6 | 4.5 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.6 | 3.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.6 | 2.6 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
| 0.6 | 10.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.6 | 10.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.6 | 4.3 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 0.6 | 8.5 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.6 | 2.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.6 | 17.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.6 | 5.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.6 | 2.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.6 | 4.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.6 | 3.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.5 | 1.6 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
| 0.5 | 9.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.5 | 3.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.5 | 3.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.5 | 1.5 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.5 | 6.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.5 | 2.0 | GO:0030519 | snoRNP binding(GO:0030519) |
| 0.5 | 4.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.5 | 10.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.5 | 8.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.5 | 8.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.5 | 1.4 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.5 | 15.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.5 | 27.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.5 | 1.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.5 | 4.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.5 | 23.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.5 | 4.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.5 | 2.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.5 | 1.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.5 | 12.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.5 | 5.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.4 | 4.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.4 | 2.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.4 | 20.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.4 | 12.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.4 | 28.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.4 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.4 | 3.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.4 | 10.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 6.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.4 | 2.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.4 | 5.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.4 | 27.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.4 | 4.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.4 | 12.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.4 | 8.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.4 | 7.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.4 | 33.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.4 | 10.6 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.4 | 2.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.4 | 26.2 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.4 | 2.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.4 | 21.7 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.4 | 1.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.4 | 19.7 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.4 | 4.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.4 | 2.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.4 | 1.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.4 | 2.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.4 | 1.1 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
| 0.4 | 30.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.4 | 4.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.4 | 2.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.4 | 3.9 | GO:0046977 | TAP binding(GO:0046977) |
| 0.4 | 3.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.4 | 2.8 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.3 | 3.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 5.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.3 | 30.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.3 | 1.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 1.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.3 | 2.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.3 | 3.4 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.3 | 5.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.3 | 58.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.3 | 0.3 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.3 | 5.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.3 | 4.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.3 | 2.2 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.3 | 4.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.3 | 3.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.3 | 6.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.3 | 8.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.3 | 6.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.3 | 1.2 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.3 | 0.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.3 | 5.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.3 | 4.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.3 | 1.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.3 | 1.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.3 | 25.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.3 | 2.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.3 | 1.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.3 | 8.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.3 | 7.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.3 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.3 | 1.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.3 | 1.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.3 | 2.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.3 | 1.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.3 | 8.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.3 | 7.4 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.3 | 3.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 1.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.3 | 1.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.3 | 11.6 | GO:0002039 | p53 binding(GO:0002039) |
| 0.3 | 9.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.3 | 0.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 4.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.3 | 1.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 4.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.2 | 3.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 1.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 9.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 10.2 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 8.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.2 | 2.5 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.2 | 8.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.2 | 7.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.2 | 33.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 7.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.2 | 10.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.2 | 11.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.2 | 6.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 13.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.2 | 2.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 5.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.2 | 292.1 | GO:0003723 | RNA binding(GO:0003723) |
| 0.2 | 4.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.2 | 20.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.2 | 3.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.2 | 72.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.2 | 2.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.2 | 6.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.2 | 3.9 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.2 | 1.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 0.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.2 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.2 | 2.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 2.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 2.0 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.2 | 2.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 14.9 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.2 | 4.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.2 | 4.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.2 | 10.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 5.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 2.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 13.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 5.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.1 | 2.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 2.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.1 | 1.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
| 0.1 | 8.9 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.1 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 2.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 1.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 1.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 1.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 4.3 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
| 0.1 | 4.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 2.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 1.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 1.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 0.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 2.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 2.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 3.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 33.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
| 0.1 | 13.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 54.2 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
| 0.1 | 3.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 5.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 2.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.8 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.1 | 2.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.1 | 4.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 2.4 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.1 | 4.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 2.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.1 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 4.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.1 | 1.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 11.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.1 | 2.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 9.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 3.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.1 | 0.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 9.2 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.1 | 1.9 | GO:0004518 | nuclease activity(GO:0004518) |
| 0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 2.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.1 | 67.7 | GO:0003676 | nucleic acid binding(GO:0003676) |
| 0.1 | 1.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.1 | 3.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.0 | 1.4 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.0 | 8.6 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 1.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 12.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.0 | 2.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.0 | 0.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 1.9 | GO:0004672 | protein kinase activity(GO:0004672) |
| 0.0 | 0.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.0 | 4.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 79.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 1.2 | 19.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.9 | 39.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.6 | 47.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.6 | 17.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.5 | 22.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.4 | 40.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.4 | 15.4 | PID ATM PATHWAY | ATM pathway |
| 0.4 | 4.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.4 | 22.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.4 | 46.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.3 | 2.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.3 | 17.0 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.3 | 24.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.3 | 6.9 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.3 | 15.6 | PID E2F PATHWAY | E2F transcription factor network |
| 0.2 | 5.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.2 | 2.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 6.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 17.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.2 | 3.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 2.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 10.5 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.2 | 2.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.2 | 4.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.2 | 7.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 11.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.2 | 8.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 1.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 3.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 8.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 4.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 3.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 11.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 10.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 1.4 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 7.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 4.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.7 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 6.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 4.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 3.8 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 2.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 1.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 2.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 10.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 6.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 4.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 4.7 | PID P73PATHWAY | p73 transcription factor network |
| 0.1 | 7.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 2.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 2.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 1.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 3.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 3.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.1 | 3.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 2.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 2.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 1.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 4.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 2.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 34.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 2.3 | 4.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.4 | 46.0 | REACTOME KINESINS | Genes involved in Kinesins |
| 1.2 | 12.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.1 | 56.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 1.1 | 23.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 1.0 | 7.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 1.0 | 7.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.0 | 12.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 1.0 | 111.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 1.0 | 1.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.9 | 19.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.9 | 16.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.9 | 7.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.9 | 11.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.8 | 5.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.8 | 20.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.8 | 18.8 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.7 | 25.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.7 | 90.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.6 | 10.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.6 | 28.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.6 | 21.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.5 | 9.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.5 | 19.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.5 | 6.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.5 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.5 | 29.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.5 | 14.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.5 | 38.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.4 | 5.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.4 | 5.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.4 | 6.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.4 | 7.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.4 | 1.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.4 | 9.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.4 | 9.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.3 | 3.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.3 | 3.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.3 | 5.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.3 | 3.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.3 | 2.0 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
| 0.3 | 13.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.3 | 7.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.3 | 6.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.3 | 4.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.3 | 21.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.3 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.3 | 3.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 2.8 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.3 | 6.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.3 | 2.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.3 | 4.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 2.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.3 | 10.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.3 | 6.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.3 | 6.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.3 | 2.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.2 | 4.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.2 | 5.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 2.9 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.2 | 1.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.2 | 2.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.2 | 4.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.2 | 6.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.2 | 4.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 2.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.2 | 6.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 27.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.2 | 17.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.2 | 9.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 4.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.2 | 3.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.2 | 4.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 5.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 4.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.2 | 1.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.2 | 0.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.2 | 4.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.2 | 2.4 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.2 | 2.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 39.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 3.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 5.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 1.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.1 | 1.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 5.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 3.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 7.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 10.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 2.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 2.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 2.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 0.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 3.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 3.7 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.1 | 1.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 3.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.0 | 5.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 1.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 1.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.0 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.0 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.0 | 3.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 1.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.0 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |